Cerebral gangliogliomas: Preoperative grading using FDT-PET and 201Tl-SPECT

American Journal of Neuroradiology

Volumn 19, Issue 5, 1998, Pages 801-806

  Kincaid, Patricia K ^a   El Saden, Suzie M ^a,b   Park, Sung Hye ^a   Goy, Barry W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GANGLIOGLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032470855     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Zentner J, Wolf HK, Ostertun B, et al. Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J Neurol Neurosurg Pychiatry 1994;57:1497-1502
2. Krouwer HGJ, Davis RL, McDermott MW, Hoshino T, Prados MD. Gangliogliomas: a clinicopathological study of 25 cases and review of the literature. J Neurooncol 1993;17:139-154
3. Courville CB, Anderson FM. Neuro-gliogenic tumours of the central nervous system: report of two additional cases of ganglioglioma of the brain. Bull L A Neurol Soc 1941;6:154-176
4. Demierre B, Stichnoth FA, Hori A. Intracerebral ganglioglioma. J Neurosurg 1986;65:177-182
5. Kalyan-Raman UP, Olivero WC. Ganglioglioma: a correlative clinicopathological and radiographical study of ten surgically treated cases with follow-up. Neurosurgery 1987;20:428-433
6. Zülch KJ. Histological Typing of Tumours of the Central Nervous System: International Classification of Tumours. No. 21. Geneva: World Health Organization; 1979:43-52
7. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-268
8. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer 1988;62: 2152-2165
9. Miller DC, Lang FF, Epstein FJ. Central nervous system gangliogliomas, 1: Pathology. J Neurosurg 1993;79:859-866
10. Kitano M, Takayama S, Nagao T, Yoshimura O. Malignant ganglioglioma of the spinal cord. Acta Pathol Jpn 1987;37:1009-1018
11. Russell DS, Rubinstein LJ. Ganglioglioma: a case with a long history and malignant evolution. J Neuropathol Exp Neurol 1962; 21:185-193
12. Lang FF, Epstein FJ, Ransohoff J, et al. Central nervous system gangliogliomas, 2: clinical outcome. J Neurosurg 1993;79:867-873
13. Garrido E, Becker LF, Hoffman HJ, Hendrick BE, Humphreys R. Gangliogliomas in children: a clinicopathological study. Childs Brain 1978;4:339-346
14. Sutton LN, Packer RJ, Rorke LB, Bruch DA, Schut L. Cerebral gangliogliomas during childhood. Neurosurgery 1983;13:124-128
15. Ventureyra E, Herder S, Mallya BK, Keene D. Temporal lobe gangliogliomas in children. Childs Nerv Syst 1986;2:63-66
16. Goldman S, Levivier M, Pirotte B, et al. Regional glucose metabolism and histopathology of gliomas: a study based on positron emission tomography-guided stereotactic biopsy. Cancer 1996;78: 1098-1106
17. Oriuchi N, Tomiyoshi K, Inoue T, et al. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med 1996;37:457-462
18. De Witte O, Levivier M, Violon P, et al. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery 1996;39:470-476
19. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma: a predictor of prognosis. Cancer 1988;62: 1074-1078
20. Di Chiro G. Positron emission tomography using 18F-fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1986;22:360-371
21. Di Chiro G, DeLaPaz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-1329
22. Hoffman JM, Hanson MW, Friedman HS, et al. FDG-PET in pediatric posterior fossa brain tumors. J Comput Assist Tomogr 1992;16:62-68
23. Tien RD, Tuori SL, Pulkingham N, Burger PC. Ganglioglioma with leptomeningeal and subarachnoid spread: results of CT, MR and PET imaging. AJR Am J Roentgenol 1992;159:391-393
24. Metsahonkala L, Aarimaa T, Sonninen P, Mikola H, Ruotsalainen U, Bergman J. CT, MRI and PET in a case of intractable epilepsy. Childs Nerv Syst 1996;12:421-424
25. Adelson PD, Peacock, WJ, Chugani HT, et al. Temporal and extended temporal resections for the treatment of intractable seizures in early childhood. Pediatr Neurosurg 1992;18:169-178
26. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989;71:342-346
27. Silver JM, Rawlings CE III, Rossitch E Jr, Zeidman SM, Freidman AH. Ganglioglioma: a clinical study with long-term follow-up. Surg Neurol 1991;35:261-266
28. Hakim R, Loeffler JS, Anthony DC, et al. Gangliogliomas in adults. Cancer 1997;79:127-131
29. Johannsson JH, Rekate HL, Roessmann U. Gangliogliomas: pathological and clinical correlation. J Neurosurg 1981;54:58-63See the article regarding spinal ganglioglioma on page 879 and commentaries on cerebral and spinal gangliogliomas on pages 807-811 of the issue.